| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.39B | 18.74B | 15.97B | 17.80B | 17.31B | 16.10B |
| Gross Profit | 6.29B | 6.49B | 5.53B | 6.51B | 4.69B | 4.62B |
| EBITDA | 3.64B | 3.46B | 2.03B | 3.06B | 2.08B | 1.83B |
| Net Income | 1.82B | 1.84B | 898.61M | 1.61B | 859.28M | 599.05M |
Balance Sheet | ||||||
| Total Assets | 20.29B | 21.46B | 19.55B | 20.18B | 20.77B | 19.74B |
| Cash, Cash Equivalents and Short-Term Investments | 4.19B | 2.55B | 1.60B | 2.98B | 1.50B | 678.00M |
| Total Debt | 2.21B | 3.85B | 4.89B | 6.25B | 6.59B | 7.76B |
| Total Liabilities | 7.55B | 8.75B | 8.72B | 11.26B | 13.36B | 13.02B |
| Stockholders Equity | 12.74B | 12.71B | 10.83B | 8.92B | 7.41B | 6.72B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.79B | 449.50M | 1.05B | 1.97B | -16.95M |
| Operating Cash Flow | 0.00 | 2.97B | 1.62B | 1.46B | 2.37B | 589.22M |
| Investing Cash Flow | 0.00 | -930.29M | -1.41B | -432.90M | -540.78M | -642.27M |
| Financing Cash Flow | 0.00 | -1.29B | -194.26M | -1.20B | -1.01B | -5.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥13.56B | 8.85 | 11.46% | 4.65% | 20.51% | 66.82% | |
80 Outperform | ¥18.95B | 5.66 | ― | 1.23% | 35.89% | 162.00% | |
75 Outperform | ¥42.06B | 14.91 | ― | 3.02% | 7.09% | 13.13% | |
70 Outperform | ¥76.45B | 15.29 | 5.37% | 3.41% | -12.80% | 4.26% | |
66 Neutral | ¥95.22B | 11.65 | ― | 2.41% | 16.05% | 3.58% | |
64 Neutral | ¥493.51B | 23.54 | ― | 2.87% | 8.99% | -43.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |